Patients with acute cerebral infarction who have motor dysfunction
Conditions
Interventions
Control group:Conventional drug therapy + 2 weeks of non-real transcranial magnetic stimulation therapy
Experimental group:Conventional drug therapy + 2 weeks of transcranial magnetic stimulation therapy
Sponsors
Suzhou Municipal Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients with hemiplegia who meet the diagnostic criteria for acute ischemic stroke and whose condition has been stable within 48 hours of onset; 2. First-time stroke, with complete clinical data; 3. Aged 18 years or older, fully informed about the information, and voluntarily participating in this study.
Exclusion criteria
Exclusion criteria: 1. Patients with combined traumatic brain injury, intracranial tumors, or cerebral hemorrhage; 2. Patients with severe heart, liver, or kidney diseases; 3. Patients with intracranial metal implants, magnetic chips, heart pacemaker implants, or skull defects; 4. Patients with severe mental illness; 5. History of using drugs that alter cortical excitability (sedatives, antidepressants); 6. Patients with severe cognitive and communication impairments who cannot cooperate or refuse to participate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fugl-Meyer assessment(FMA) Score;Modified Rankin Scale(mRS) Score;National Institute of Health Stroke Scale(NIHSS) Score; | — |
Countries
China
Contacts
Public ContactChen Lei
Suzhou Municipal Hospital
Outcome results
None listed